Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020-December 2020.

COVID-19 COVID-19 Testing Humans SARS-CoV-2 Sensitivity and Specificity Wisconsin / epidemiology
BinaxNOW COVID-19 SARS-CoV-2 antigen testing diagnostic performance

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
15 07 2021
Historique:
pubmed: 29 4 2021
medline: 21 7 2021
entrez: 28 4 2021
Statut: ppublish

Résumé

Repeating the BinaxNOW antigen test for severe acute respiratory syndrome coronavirus 2 using 2 groups of readers within 30 minutes resulted in high concordance (98.9%) in 2110 encounters. Same-day repeat antigen testing did not significantly improve test sensitivity (77.2% to 81.4%) while specificity remained high (99.6%).

Identifiants

DOI: 10.1093/cid/ciab309 PMID: 33909068 PMC: PMC8135465
pubmed: 33909068
pii: 6257223
doi: 10.1093/cid/ciab309
pmc: PMC8135465
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

S54-S57

Subventions

Organisme : CDC HHS
Pays : United States

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2021.

Auteurs

Melisa M Shah (MM)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Phillip P Salvatore (PP)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Laura Ford (L)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Emiko Kamitani (E)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Melissa J Whaley (MJ)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Kaitlin Mitchell (K)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Dustin W Currie (DW)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Clint N Morgan (CN)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Hannah E Segaloff (HE)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Wisconsin Department of Health Services, Madison, Wisconsin, USA.

Shirley Lecher (S)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Tarah Somers (T)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Miriam E Van Dyke (ME)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

John Paul Bigouette (JP)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Augustina Delaney (A)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Juliana DaSilva (J)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Michelle O'Hegarty (M)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Lauren Boyle-Estheimer (L)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Fatima Abdirizak (F)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sandor E Karpathy (SE)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jennifer Meece (J)

Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.

Lynn Ivanic (L)

Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.

Kimberly Goffard (K)

Winnebago County Health Department, Oshkosh, Wisconsin, USA.

Doug Gieryn (D)

Winnebago County Health Department, Oshkosh, Wisconsin, USA.

Alana Sterkel (A)

Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA.

Allen Bateman (A)

Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA.

Juliana Kahrs (J)

University of Wisconsin-Oshkosh, Oshkosh, Wisconsin, USA.

Kimberly Langolf (K)

University of Wisconsin-Oshkosh, Oshkosh, Wisconsin, USA.

Tara Zochert (T)

University of Wisconsin-Oshkosh, Oshkosh, Wisconsin, USA.

Nancy W Knight (NW)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Christopher H Hsu (CH)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Hannah L Kirking (HL)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jacqueline E Tate (JE)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Performance of Repeat BinaxNOW Severe Acute...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Dépistage de la COVID-19 › Performance of Repeat BinaxNOW Severe Acute...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Performance of Repeat BinaxNOW Severe Acute...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Performance of Repeat BinaxNOW Severe Acute...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Sensibilité et spécificité › Performance of Repeat BinaxNOW Severe Acute...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › États-Unis › États du Centre-Ouest des États-Unis › Wisconsin › Performance of Repeat BinaxNOW Severe Acute...